Humana Inc. Stock

Equities

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse 04:00:02 2024-04-23 pm EDT 5-day change 1st Jan Change
328 USD +0.82% Intraday chart for Humana Inc. +3.29% -28.36%
Sales 2024 * 112B Sales 2025 * 116B Capitalization 39.54B
Net income 2024 * 1.91B Net income 2025 * 2.71B EV / Sales 2024 * 0.41 x
Net Debt 2024 * 6.63B Net Debt 2025 * 5.09B EV / Sales 2025 * 0.39 x
P/E ratio 2024 *
20.8 x
P/E ratio 2025 *
14.4 x
Employees 67,600
Yield 2024 *
1.17%
Yield 2025 *
1.26%
Free-Float 61.06%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.14%
1 week+3.29%
Current month-5.40%
1 month-5.90%
3 months-19.52%
6 months-36.37%
Current year-28.36%
More quotes
1 week
320.47
Extreme 320.47
334.42
1 month
299.23
Extreme 299.23
353.00
Current year
299.23
Extreme 299.23
475.00
1 year
299.23
Extreme 299.23
541.21
3 years
299.23
Extreme 299.23
571.30
5 years
208.25
Extreme 208.25
571.30
10 years
107.91
Extreme 107.91
571.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 11-11-30
Director of Finance/CFO 50 05-12-31
Chief Administrative Officer 57 12-11-30
Members of the board TitleAgeSince
Director/Board Member 60 22-08-31
Chairman 63 03-06-30
Director/Board Member 67 19-09-22
More insiders
Date Price Change Volume
24-04-23 328 +0.82% 1,624,723
24-04-22 325.3 -0.92% 1,591,093
24-04-19 328.3 +1.08% 1,143,745
24-04-18 324.8 +0.42% 1,557,433
24-04-17 323.5 +1.87% 1,958,774

Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT

More quotes
Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
328 USD
Average target price
388.6 USD
Spread / Average Target
+18.50%
Consensus